KC
SNCE

Kepos Capital’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Kepos Capital’s Portfolio SNCE Stock Details SNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,500
Closed -$490K – 713
2021
Q3 		$490K Buy
+2,500
New +$499K 0.03% 359
2021
Q1 		– Sell
-3,990
Closed -$851K – 456
2020
Q4 		$851K Buy
+3,990
New +$830K 0.08% 211

Other funds holding SNCE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Kepos Capital's SNCE Position: Q4 2021 in Review

Kepos Capital sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q4 2021, closing a stake of 2,500 shares — an estimated $490K sold.

Kepos Capital first reported a position in SNCE in Q4 2020 and held it in 2 quarters. The position peaked at $851K in Q4 2020. 39 funds tracked by Wall St. Rank hold SNCE as of Q4 2021.

  • Kepos Capital reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Kepos Capital sold 2,500 Science 37 Holdings, Inc. Common Stock shares in Q4 2021, an estimated $490K.
  • Kepos Capital first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Kepos Capital's Science 37 Holdings, Inc. Common Stock position peaked at $851K in Q4 2020.
  • 39 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q4 2021.

Based on Kepos Capital's 13F filing for Q4 2021, filed 14 Feb 2022.